Complications after colorectal anastomosis in a patient with metastatic rectal cancer treated with systemic chemotherapy and bevacizumab.
Akkouche
Amine
A
Department of Surgery, Maisonneuve-Rosemont Hospital, University of Montreal, Montréal, Que.
Sidéris
Lucas
L
Leblanc
Guy
G
Leclerc
Yves-E
YE
Vafiadis
Petro
P
Dubé
Pierre
P
D000714:Anastomosis, Surgical; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000068258:Bevacizumab; D003106:Colon / Q000601:surgery; D003131:Combined Modality Therapy; D000075202:Contraindications; D013505:Digestive System Surgical Procedures; D006801:Humans; D007813:Laparotomy; D008113:Liver Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D012007:Rectum / Q000601:surgery; D013997:Time Factors
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab